跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
IRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML
Approved
THERAPEUTIC
IRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML
Intas Pharmaceuticals Limited
🇸🇬 Health Sciences Authority
Approval Date
Jul 5, 2019
Approval ID
9343f2264c46d72e
Company
Intas Pharmaceuticals Limited
Type
Therapeutic
Approval Details
Approval Id
9343f2264c46d72e
Drug Name
IRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML
Product Name
IRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML
Approval Number
SIN15734P
Approval Date
2019-07-05
Registrant
ACCORD HEALTHCARE PRIVATE LIMITED
Licence Holder
ACCORD HEALTHCARE PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01XX19
Atc Item Name
xl 01 xx 19
Pharma Manufacturer Name
ACCORD HEALTHCARE PRIVATE LIMITED
Company Detail Path
/organization/accord-healthcare-private-limited
Active Ingredients
Irinotecan 86.65 mg eqv to Irinotecan Hydrochloride Trihydrate
100 mg/vial
Irinotecan 86.65 mg eqv to Irinotecan Hydrochloride Trihydrate
100 mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 5, 2019
Approval ID
9343f2264c46d72e
Type
Therapeutic
Back to HSA Approvals